SQW is a leading economic & management consultancy based in Cambridge, Edinburgh, Leeds, Manchester, London and Hong Kong. Our core skills lie in delivering practical policy and management solutions in science & technology, education, SME support, and regional development.
|Address:||Reuben House, Covent Garden, Cambridge|
|Membership type:||Corporate 6-20 (£250+VAT pa)|
SQW was founded in 1983. Consultants are drawn from academia, government, industry and the development agencies. Our clients include international bodies, such as the World Bank and the European Commission, government departments in the UK and overseas, several directorates of the European Commission, major charitable foundations, private firms and a wide range of regional development agencies and local authorities. Our HQ is in Cambridge and our other offices are in Edinburgh, London, Leeds, Manchester and Hong Kong.
The firm's skill base centres on wealth creation and the ways in which it may be enhanced through policies, programmes and projects at national, regional and local levels. Many of our staff have economics or related qualifications, but we also employ staff whose degrees were in scientific or other disciplines. Senior staff typically have wide experience of strategy development and review, feasibility and evaluation assignments and there is also a specialist capability in performance measurement. They are supported by research consultants, who assist in surveys, data assembly and analysis.
In terms of subject matter SQW has a distinctive strength in relation to the organisation and effectiveness of research policies and programmes. This links across to the commercialisation of research through technology transfer and new firm starts. We have also undertaken a range of work exploring the, currently fashionable, topic of clusters and recently published a new book on the Cambridge Phenomenon. SQW also has a strong record in working across the range of tasks being developed by the UK Regional Development Agencies, drawing on our strengths in SME development, skills, strategic planning, programme review and the design of performance measurement and monitoring systems.
Oxford Innovation has been appointed by the Welsh Government to deliver a new programme that will assist start-up and early stage life sciences firms with high growth potential to grow more rapidly over the next three years.
20 January 2012Read in full
Oxford Investment Opportunity Network (OION), Europe’s leading technology business angel network, is to participate in the Business Angel Co-investment Fund (Angel CoFund) announced by the government that will provide £50 million to invest in high growth companies alongside business angels.
30 November 2011Read in full
Scott Bader Innovation Centre in Northamptonshire was officially launched last week as part of the Global Entrepreneurship Week celebrations, with the first occupier set to move in next month.
21 November 2011Read in full
Adaptimmune, which is pioneering enhanced T cell receptor-driven T cells for the treatment of cancer and infectious disease, announces two new Board appointments with immediate effect. Dr Jonathan Knowles joins the Board as a non-executive director and Dr Helen Tayton-Martin, Adaptimmune’s Chief Operating Officer, becomes an executive director.
20 September 2011Read in full
Harborough Innovation Centre, designed as a hub for local businesses to launch, innovate and grow, has welcomed its first occupiers. Four companies have moved into office premises at the Centre and one of the businesses is Sporting Edge which was set up by former Leicestershire and England cricketer Jeremy Snape.
15 August 2011Read in full
Microvisk Technologies has introduced its unique handheld devices which monitor the blood clotting status of patients to the US market. The Microvisk devices attracted strong interest from distributors and potential partners ahead of clinical trials in major US medical centres this autumn and product launches in 2012.
15 August 2011Read in full
Scott Bader has announced that it is creating an innovation centre for start-up companies in the specialty chemicals, composites and coatings sectors. Opening on 1 July, Scott Bader Innovation Centre will provide shared laboratory space and high quality offices on the company’s state-of-the-art R&D headquarters site at Wollaston, Northamptonshire.
28 June 2011Read in full
The Market Harborough Innovation and Business Centre, which will be a hub for local businesses to launch, innovate and grow, has been officially handed over by developer William Davis Ltd to Harborough District Council. The ceremony also marked the formal appointment of Oxford Innovation to manage the Innovation Centre.
15 June 2011Read in full
Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri.
14 June 2011Read in full
Oxford Investment Opportunity Network (OION), Europe’s leading technology business angel network, has welcomed the Government’s announcement of the Regional Growth Fund which looks likely to provide £50 million for the development of a national fund to invest in high growth start-ups alongside business angels.
19 April 2011Read in full